Консенсус экспертов по использованию режимов гипофракционирования дозы у больных с злокачественными новообразованиями головного мозга, головы и шеи, раком молочной железы, прямой кишки и предстательной железы. Белые ночи 2025

Sergey N. Novikov; Irina A. Akulova; Elena R. Vetlova; Artem R. Gevorkov; Andrei V. Golanov; Konstantin B. Gordon; Pavel V. Datsenko; Timur R. Izmailov; Sergei V. Medvedev; Natalia IU. Neklasova; Ivan K. Osinov; Oksana P. Trofimova; Elena I. Tiuriaeva; Marina V. CHernykh; Sergei V. Usychkin

doi:10.37469/0507-3758-2026-72-2-OF-2595

Vol. 72 No. 2 (2026), EXPERT OPINION

Vol. 72 No. 2 (2026)

Expert Consensus on the Use of Hypofractionated Radiotherapy for Brain, Head and Neck, Breast, Colorectal, and Prostate Cancer. White Nights 2025

EXPERT OPINION

https://doi.org/10.37469/0507-3758-2026-72-2-OF-2595

Published 08.05.2026

Sergey N. Novikov

N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, the Russian Federation

https://orcid.org/0000-0002-7185-1967

Irina A. Akulova

N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, the Russian Federation

https://orcid.org/0000-0003-0018-7197

Elena R. Vetlova

N.N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russian Federation

https://orcid.org/0000-0002-4904-0324

Artem R. Gevorkov

P.A. Herzen Moscow State Research Institute – a branch of FSBI National Medical Research Radiological Centre of the Ministry of Health of Russia, Moscow, Russian Federation

https://orcid.org/0000-0002-9181-7811

Andrei V. Golanov

N.N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russian Federation

https://orcid.org/0000-0002-0976-4547

Konstantin B. Gordon

A.F. Tsyba Medical Radiological Scientific Center – Branch of the Federal State Budgetary Institution National Medical Research Center for Radiology, Obninsk, Russian Federation

https://orcid.org/0000-0002-3146-5615

Pavel V. Datsenko

P.A. Herzen Moscow State Research Institute – a branch of FSBI National Medical Research Radiological Centre of the Ministry of Health of Russia, Moscow, Russian Federation

https://orcid.org/0000-0002-9808-2328

Timur R. Izmailov

N.I. Pirogov National Medical and Surgical Center, Moscow, Russian Federation

https://orcid.org/0000-0002-0749-6446

Sergei V. Medvedev

P.A. Herzen Moscow State Research Institute – a branch of FSBI National Medical Research Radiological Centre of the Ministry of Health of Russia, Moscow, Russian Federation

https://orcid.org/0000-0002-6057-1230

Natalia IU. Neklasova

A.M. Granov Russian Research Center for Radiology and Surgical Technologies, St. Petersburg, Russian Federation

https://orcid.org/0009-0004-8657-9494

Ivan K. Osinov

JSC “Neurosurgery Business Center,” Moscow, Russian Federation

https://orcid.org/0000-0003-0747-9037

Oksana P. Trofimova

N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation

https://orcid.org/0000-0002-7204-370X

Elena I. Tiuriaeva

N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russian Federation

https://orcid.org/0009-0001-4546-447X

Marina V. CHernykh

N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation

https://orcid.org/0000-0003-4944-4035

Sergei V. Usychkin

Medscan, Branch of Limited Liability Company "Hadera Medical LTD, Moscow, Russian Federation

https://orcid.org/0009-0002-7250-3363

##article.numberofdownloads## 25

##article.numberofdownloads## 3

##article.numberofviews## 84

pdf (Русский)

pdf suppl (Русский)

Keywords

White Nights Consensus
brain tumors
head and neck tumors
breast cancer
rectal cancer
prostate cancer
adiation therapy
hypofractionation

How to Cite

Novikov, S. N., Akulova, I. A., Vetlova, E. R., Gevorkov, A. R., Golanov, A. V., Gordon, K. B., Datsenko, P. V., Izmailov, T. R., Medvedev, S. V., Neklasova, N. I., Osinov, I. K., Trofimova, O. P., Tiuriaeva, E. I., CHernykh, M. V., & Usychkin, S. V. (2026). Expert Consensus on the Use of Hypofractionated Radiotherapy for Brain, Head and Neck, Breast, Colorectal, and Prostate Cancer. White Nights 2025. Voprosy Onkologii, 72(2), OF–2595. https://doi.org/10.37469/0507-3758-2026-72-2-OF-2595

Abstract

This article presents the results of an expert consensus vote on the use of hypofractionated radiotherapy for malignant tumors of various sites. The voting focused on the most pertinent and contentious issues in the treatment of brain, head and neck, breast, rectal, and prostate cancers.

A panel of 46 leading experts in radiation oncology voted on 14 questions divided into five sections during a live session. Consensus, defined as ≥ 70% agreement, was required for a recommendation to be considered valid, given the intended application of these results to inform clinical practice guidelines.

https://doi.org/10.37469/0507-3758-2026-72-2-OF-2595

##article.numberofdownloads## 25

##article.numberofdownloads## 3

##article.numberofviews## 84

pdf (Русский)

pdf suppl (Русский)

References

Malmström A., Grønberg B.H., Marosi C., et al. Temozolo-mide versus standard 6-week radiotherapy versus hypofrac-tionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012; 13(9): 916-26.-DOI: https://doi.org/10.1016/S1470-2045(12)70265-6.

Roa W., Kepka L., Narendra Kumar N., et al. International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol. 2015; 10; 33(35): 4145-50.-DOI: https://doi.org/10.1200/JCO.2015.62.6606.

Чугуев А.С., Герасимов В.А., Каприн А.Д., Даценко П.В. Результаты исследования двух режимов фракционирования при глиомах 4 степени злока-чественности. Вопросы онкологии. 2025; 71(5): 995-1003.-DOI: https://doi.org/10.37469/0507-3758-2025-71-5-OF-2206. [Chuguev A.S., Gerasimov V.A., Kaprin A.D., Datsenko P.V. Results of the study of two fractionation regimens in grade 4 gliomas. Voprosy Onkologii = Problems in Oncology. 2025; 71(5): 995-1003.-DOI: https://doi.org/10.37469/0507-3758-2025-71-5-OF-2206 (In Rus)].

Hingorani M., Colley W.P., Dixit S., Beavis A.M. Hypofrac-tionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future? Br J Radiol. 2012; 85(1017): 770-781.-DOI: https://doi.org/10.1259/bjr/83827377.

Perlow H.K., Prasad R.N., Yang M., et al. Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials. Cancer. 2022; 128(12): 2367-2374.-DOI: https://doi.org/10.1002/cncr.34192.

Liao G., Zhao Z., Yang H., Li X. Efficacy and safety of hypofractionated radiotherapy for the treatment of newly diagnosed glioblastoma multiforme: A systematic review and meta-analysis. Front Oncol. 2019; 9: 1017.-DOI: https://doi.org/10.3389/fonc.2019.01017.

Ziu M., Kim B.Y.S., Jiang W., et al. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update. J Neurooncol. 2020; 150(2): 215-267.-DOI: https://doi.org/10.1007/s11060-020-03612-7.

Marcu L.G. Radiation therapy fractionation in the modern era of head and neck oncology towards an improved therapeutic window. Academia Oncology. 2024; 1.-DOI: https://doi.org/10.20935/AcadOnco7352.

Eom K.Y. Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy. Radiat Oncol J. 2024; 42(1): 1-3.-DOI: https://doi.org/10.3857/roj.2024.00178.

Gupta T., Ghosh-Laskar S., Agarwal J.P. Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era. Oral Oncol. 2020; 111: 105045.-DOI: https://doi.org/10.1016/j.oraloncology.2020.105045.

Frykholm G.J., Glimelius B., Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum. 1993; 36(6): 564-572.-DOI: https://doi.org/10.1007/BF02049863.

Swedish Rectal Cancer Trial, Cedermark B., Dahlberg M., et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997; 336(14): 980-987.-DOI: https://doi.org/10.1056/NEJM199704033361402.

Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006; 93(10): 1215-1223.-DOI: https://doi.org/10.1002/bjs.5506.

Ngan S.Y., Burmeister B., Fisher R.J., et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol. 2012; 30(31): 3827-3833.-DOI: https://doi.org/10.1200/JCO.2012.42.9597.

Erlandsson J., Lörinc E., Ahlberg M., et al. Tumour regression after radiotherapy for rectal cancer — Results from the randomised Stockholm III trial. Radiother Oncol. 2019; 135: 178-186.-DOI: https://doi.org/10.1016/j.radonc.2019.03.016.

Ciseł B., Pietrzak L., Michalski W., et al. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol. 2019; 30(8): 1298-1303.-DOI: https://doi.org/10.1093/annonc/mdz186.

Bahadoer R.R., Dijkstra E.A., van Etten B., et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021; 22(1): 29-42.-DOI: https://doi.org/10.1016/S1470-2045(20)30555-6.

Jin J., Tang Y., Hu C., et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022; 40(15): 1681-1692.-DOI: https://doi.org/10.1200/JCO.21.01667.

Ищанов Д.Г., Черных М.В., Иванов В.А., et al. Сравнение непосредственных результатов неоадъювантной дистанционной лучевой терапии больных раком прямой кишки в период пандемии новой коронавирусной инфекции. Многоцентровое ретроспективное исследование с использованием псевдорандомизации. Вопросы онкологии. 2025; 71(5): OF–2380.-DOI: https://doi.org/10.37469/0507-3758-2025-71-5-OF-2380. Ichshanov D.G., Cherhykh M.V., Ivanov V.A., et al. Comparison of immediate out-comes of neoadjuvant radiotherapy for rectal cancer during the COVID-19 pandemic. A propensity score-matched multicenter retrospective study. Voprosy Onkologii = Problems in Oncology. 2025; 71(5): OF–2380.-DOI: https://doi.org/10.37469/0507-3758-2025-71-5-OF-2380 (In Rus)].

Patel A., Spychalski P., Corrao G., et al. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis. Acta Oncol. 2021; 60(10): 1308-1316.-DOI: https://doi.org/10.1080/0284186X.2021.1953137.

Giunta E.F., Bregni G., Pretta A., et al. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials. Cancer Treat Rev. 2021; 96: 102177.-DOI: https://doi.org/10.1016/j.ctrv.2021.102177.

Dijkstra E.A., Nilsson P.J., Hospers G.A.P., et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: A 5-year follow-up of the RAPIDO trial. Ann Surg. 2023; 278(4): e766-e772.-DOI: https://doi.org/10.1097/SLA.0000000000005799.

Bercz A., Park B.K., Pappou E., et al. Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy. Ann Oncol. 2024; 35(11): 1003-1014.-DOI: https://doi.org/10.1016/j.annonc.2024.07.729.

Socha J., Kairevice L., Kępka L., et al. Should short-course neoadjuvant radiation therapy be applied for low-lying rectal cancer? A systematic review and meta-analysis of the randomized trials. Int J Radiat Oncol Biol Phys. 2020; 108(5): 1257-1264.-DOI: https://doi.org/10.1016/j.ijrobp.2020.06.077.

Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002; 94(15): 1143-1150.-DOI: https://doi.org/10.1093/jnci/94.15.1143.

Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362(6): 513-520.-DOI: https://doi.org/10.1056/NEJMoa0906260.

START Trialists' Group, Bentzen S.M., Agrawal R.K., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008; 9(4): 331-341.-DOI: https://doi.org/10.1016/S1470-2045(08)70077-9.

START Trialists' Group, Bentzen S.M., Agrawal R.K., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet. 2008; 371(9618): 1098-1107.-DOI: https://doi.org/10.1016/S0140-6736(08)60348-7.

Smith B.D., Bentzen S.M., Correa C.R., et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011; 81(1): 59-68.-DOI: https://doi.org/10.1016/j.ijrobp.2010.04.042.

Offersen B.V., Alsner J., Nielsen H.M., et al. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial. J Clin Oncol. 2020; 38(31): 3615-3625.-DOI: https://doi.org/10.1200/JCO.20.01363.

Wang S.L., Fang H., Song Y.W., et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019; 20(3): 352-360.-DOI: https://doi.org/10.1016/S1470-2045(18)30813-1.

Brion T., Ghodssighassemabadi R., Auzac G., et al. Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial. Radiother Oncol. 2025; 207: 110849.-DOI: https://doi.org/10.1016/j.radonc.2025.110849.

Kishan A.U., Sun Y., Tree A.C., et al. Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium. Lancet Oncol. 2025; 26(4): 459-469.-DOI: https://doi.org/10.1016/S1470-2045(25)00034-8.

Widmark A., Gunnlaugsson A., Beckman L., et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet. 2019; 394(10196): 385-395.-DOI: https://doi.org/10.1016/S0140-6736(19)31131-6.

Dearnaley D., Syndikus I., Mossop H., et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016; 17(8): 1047-1060.-DOI: https://doi.org/10.1016/S1470-2045(16)30102-4.

van As N., Griffin C., Tree A., et al. Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer. N Engl J Med. 2024; 391(15): 1413-1425.-DOI: https://doi.org/10.1056/NEJMoa2403365.

Lehrer E.J., Kishan A.U., Yu J.B., et al. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials. Radiother Oncol. 2020; 148: 235-242.-DOI: https://doi.org/10.1016/j.radonc.2020.04.037.

Draulans C., Haustermans K., Pos F.J., et al. Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial. Radiother Oncol. 2024; 201: 110568.-DOI: https://doi.org/10.1016/j.radonc.2024.110568.

Mohamad O., Zamboglou C., Zilli T., et al. Safety of ultrahypofractionated pelvic nodal irradiation in the definitive management of prostate cancer: systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2024; 118(4): 998-1010.-DOI: https://doi.org/10.1016/j.ijrobp.2023.09.053.

Murthy V., Mallick I., Maitre P., et al. Pelvic regional control with 25 Gy in 5 fractions in stereotactic radiation therapy for high-risk prostate cancer: Pooled prospective outcomes from the SHARP consortium. Int J Radiat Oncol Biol Phys. 2025; 122(1): 93-98.-DOI: https://doi.org/10.1016/j.ijrobp.2024.12.018.

Самарцева Е.Е., Новиков С.Н., Ильин Н.Д., et al. Использование режима умеренного гипофракционирования дозы при облучении тазовых лимфатических узлов у больных раком предстательной железы высокого и очень высокого риска рецидива: предварительные результаты. Вопросы онкологии. 2025; 71(5): 1070-1081.-DOI: https://doi.org/10.37469/0507-3758-2025-71-5-of-2451. [Smartseva E.E., Novikov S.N., Ilyin N.D., et al. Moderate hypofractionation of dose in pelvic lymph node ir-radiation for patients with high and very high risk prostate cancer: preliminary results. Voprosy Onkologii = Problems in Oncology. 2025; 71(5): 1070-1081.-DOI: https://doi.org/10.37469/0507-3758-2025-71-5-of-2451 (In Rus)].

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Vladimir F. Semiglazov, Petr V. Krivorotko, Tatiana Y. Semiglazova, Elena V. Artamonova, Anna S. Artemyeva, Svetlana G. Bagrova, Larisa V. Bolotina, Elena M. Bit-Sava , Alla A. Bozhok, Lubov Yu. Vladimirova, Vera А. Gorbunova, Haykuhi K. Geokchyan-Kzhdryan, Natalia V. Dengina, Ludmila G. Zhukovа, Aziz D. Zikiryakhodjaev, Evgeny N. Imyanitov, Irina V. Kolyadina, Irina A. Koroleva, Asel G. Kudaibergenova, Alexey G. Manikhas, Sergey N. Novikov, Rashida V. Orlova, Ruslan M. Paltuev, Alexander V. Petrovsky, Anastasiia A. Parokonnaia, Sergey M. Portnoj, Grigory A. Raskin, Valerii V. Rodionov, Nikita A. Savelov, Vladislav V. Semiglazov, Marina B. Stenina, Kaldygul K. Smagulova, Daniil L. Stroyakovskiy, Eldar E. Topuzov, Oxana P. Trofimova, Mona A. Frolova, Olga S. Khodorovich, Yuliana S. Shatova, I St. Petersburg International Consensus on the Diagnosis and Treatment of Breast Cancer «White Nights 2024» , Voprosy onkologii: Vol. 70 No. 6 (2024)
Alexey M. Belyaev, Vladimir F. Semiglazov, Sergey S. Bagnenko, Sergey V. Kirichuk, Alexander N. Stukov, Aleksei V. Gulyaev, Sergey N. Novikov, Elena V. Bakhidze, Asel G. Kudaibergenova, Vladislav V. Semiglazov, Nickolay S. Ustimov, Mariia N. Filkovskaia, Maria S. Kobysheva, Tatiana Yu. Semiglazova, The Institute of Oncology during the Great Patriotic War. Dedicated to the 80th anniversary of the Great Victory. , Voprosy onkologii: Vol. 71 No. 2 (2025)
Petr V. Krivorotko, Nikolay S. Amirov, Anna S. Artemyeva, Ekaterina A. Busko, Tengiz T. Tabagua, Alexander S. Emelyanov , Sergey S. Yereschenko , Roman S. Pesotsky, Viktoriia V. Mortada, Konstantin Yu. Zernov, Elena K. Ziltsova, Larisa P. Gigolaeva, Kirill S. Nikolaev, Alexander V. Komyahov, Yana I. Bondarchuk, Diana A. Enaldieva, Nestan Bekkeldiyeva, Daria Ulrikh, Sergey N. Novikov, Pavel I. Krzhivitskiy, Zhanna V. Bryantseva, Irina A. Akulova, Roman V. Donskikh, Vladimir F. Semiglazov, Aleksey M. Belyaev, Treatment Outcomes Evaluation in Breast Cancer Patients with a Pathological Complete Response after Neoadjuvant Systemic Therapy Depending on Different Types of Local Treatment , Voprosy onkologii: Vol. 70 No. 2 (2024)
Tatiana I. Sevostyanova, Tatiana Yu. Semiglazova, Olga I. Ponasenko, Шейда Раджабали кызы Абдуллаева, Larisa V. Filatova, Zhanna V. Bryantseva, Irina A. Akulova, Boris S. Kasparov, Vladislav V. Semiglazov, Petr V. Krivorotko, Sergey N. Novikov, Vladimir F. Semiglazov, Artur Y. Malygin, Veronika V. Klimenko, Rashida V. Orlova, Mark I. Gluzman, Anna E. Protasova, Nadezhda V. Kryukova, Elena M. Pavlova, Maria I. Dolgaleva, Eugenia Y. Zubareva, Andrey P. Galin, Sergey I. Gvozdarev, Alexey M. Belyaev , Study of the Efficacy and Safety of Stereotactic Radiation Therapy in Combination with Trastuzumab Emtansine Immunoconjugate in Patients with HER-2-positive Oligometastatic Breast Cancer. Interim Results , Voprosy onkologii: Vol. 71 No. 3 (2025)
Zhanna V. Bryantseva, Irina A. Akulova, Sergey N. Novikov, Petr V. Krivorotko, Tengiz T. Tabagua , Alexander S. Emelyanov, Arina O. Gorina, Tatyana S. Yaganova, Daria G Ulrikh , Interim Results of the De-Escalation of Adjuvant Radiotherapy in Patients with Early Breast Cancer Involving One to Three Axillary Lymph Nodes , Voprosy onkologii: Vol. 71 No. 1 (2025)
Andrey A. Yarovoy, Andrey V. Golanov, Aiza G. Galbatsova, Valery V. Kostyushenko, Ivan K. Osinov, Vera A. Yarovaya, Stereotactic Gamma Knife Radiosurgery for Uveal Melanoma: 10-year Experience , Voprosy onkologii: Vol. 70 No. 4 (2024)
Sergey N. Novikov, Nikolay D. Ilyin, Yulia S. Melnik, Olga I. Ponomareva, Roman V. Novikov, Yuriy O. Merezhko, Ekaterina E. Samartseva, Maria Yu. Gotovchikova, Andrey I. Arsenev, Filipp E. Antipov, Vasiliy K. Karandashov, Sergey M. Gozalishvili, Nikita O. Kuznetsov, Sergey V. Kanaev, Experience of Using Stereotactic Ablative Radiotherapy for Radical Treatment of Low and Intermediate Risk Prostate Cancer , Voprosy onkologii: Vol. 70 No. 2 (2024)
Sergey N. Novikov, Elena I. Tiuriaeva, Roman V. Novikov, Denis V. Samsonov, Pavel Y. Grishko, Marina V. Grinkevitch, Alexey M. Karatchun, Oleg B. Tkatchenko, Elena V. Tkatchenko, Yulia S. Melnik, Yulia P. Shishkanova, Olga I. Ponomareva, Sergey S. Litinsky, Сергей Валерьевич Кондратьев, Maxim I. Sluzhev, Alexandr V. Kornilov, Alexandra Y. Olkina, Alexandra N. Sidorova, Liia M. Savel'eva, Anton Y. Zozulia, Sergey V. Kanaev, Alexey M. Belyaev, High-Dose-Rate Endorectal Brachytherapy Boost for Low-Lying Rectal Cancer: Predictors of Complete Clinical Response , Voprosy onkologii: Vol. 71 No. 5 (2025)
Irina A. Akulova, Zhanna V. Bryantseva, Sergey N. Novikov, Petr V. Krivorotko, Tengiz T. Tabagua, Alexander S. Emelyanov, Tatyana S. Yaganova, Sergey V. Kanaev, Alexey M. Belyaev, Clinical Results of Moderate aAnd Ultrahypofractionated Postoperative Radiotherapy sfter Breast-Conserving Surgery in Patients with Early Breast Cancer , Voprosy onkologii: Vol. 71 No. 3 (2025)
Sergey N. Novikov, Introductory Remarks, Doctor of Medical Sciences, Professor Novikov S.N. , Voprosy onkologii: Vol. 71 No. 5 (2025)